Congratulations to Evi Llabani
Evi Llabani receives the inaugural C*Star Fellowship from the Cancer Center at Illinois ...
Read More
Read More
Vanquish Oncology, Inc. announces multimillion dollar investment to move PAC-1 to human clinical trials for cancer patients.
Cancer drug tested in pet dogs is now bound for human trials. University of Illinois chemistry professor Paul Hergenrother, left, ...
Read More
Read More
